4.0 Article

Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucuman, Argentina

Journal

LANCET REGIONAL HEALTH-AMERICAS
Volume 6, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.lana.2021.100123

Keywords

SPUTNIK V; Gam-COVID-Vac; COVID-19; SARS-CoV-2; Humoral inmune response; Seroconversion; Long term immunity; RBD spike

Funding

  1. Tucuman Public Health System (SIPROSA)
  2. Argentinean National Research Council (CONICET)
  3. National University of Tucuman (UNT)

Ask authors/readers for more resources

This study investigated the long-term humoral immune response in volunteers who received SPUTNIK V. The findings showed that antibodies peaked at 28 days post-vaccination and declined afterwards, but remained detectable in 94% of individuals at 90 days. Previous infection triggered a stronger immune response and increased neutralization activity against variants of concern. Basal antibody titers had a greater influence on postvaccination immune responses.
Background Gam-COVID-Vac (SPUTNIK V) has been granted emergency use authorization in 70 nations and has been administered to millions worldwide. However, there are very few peer-reviewed studies describing its effects. Independent reports regarding safety and effectiveness could accelerate the final approval by the WHO. We aimed to study the long-term humoral immune response in nayve and previously infected volunteers who received SPUTNIK V. Methods Humoral immune responses, assayed by anti-SARS-CoV-2-spike-RBD IgG ELISA and neutralization assays, were measured in 602 healthcare workers at 0, 14, 28, 60 and 180 days after receiving SPUTNIK V between December 2020 and July 2021 in Tucuman, Argentina. Findings Seroconversion was detected in 97% of individuals after 28 days post-vaccination (dpv) (N = 405). Anti-RBD titers began to decrease after 60 dpv (N = 328), but remained detectable in 94% at 90 dpv (N = 224). At 180 dpv, anti-RDB titers persisted in 31% (N = 146). Previous infection triggered an increased immune response to the first dose and increased neutralization activity against variants of concern (VOC). Second doses in previously infected individuals further increased titers, even 90 dpv (N = 75). Basal antibody titers had more influence on postvaccination anti-RBD responses than the time elapsed between diagnosis and vaccination (N = 274). Interpretation Data presented herein provides essential knowledge regarding the kinetics of antibodies induced by SPUTNIK V up to six months after immunization, and suggests that when considering one-dose vaccination policies for individuals with previous SARS-CoV-2 infection, serological studies to determine basal titers may be important, independent of when diagnosis occurred. Copyright (c) 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available